Synthesis of Fibrin Clot from Fibrinogen Platelet Rich Plasma (PRP) for Scaffold Applications
International Journal of Electrical, Computer, and Biomedical Engineering · 2023
DOI: 10.62146/ijecbe.v1i1.11 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Electrical, Computer, and Biomedical Engineering, 2023. Verfasst von Siti Fauziyah Rahman. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Platelet-rich plasma (PRP), which contains fibrinogen, is activated by the addition of thrombin and calcium chloride to create fibrin clots. Fibrin is a natural biopolymer that can be applied for medical applications. This study aims to synthesize fibrin clots from fibrinogen platelet-rich plasma for scaffold applications. The optimum amount of fibrin clot can be obtained by varying the ratio of PRP to a mixture of CaCl2 with the variation of 9:1, 10:1, and 11:1. The highest fibrin clot produced was 5.925 ml with 5.5% CaCl2.
Zitieren
APA
Rahman, S. F. (2023). Synthesis of Fibrin Clot from Fibrinogen Platelet Rich Plasma (PRP) for Scaffold Applications. International Journal of Electrical, Computer, and Biomedical Engineering. https://doi.org/10.62146/ijecbe.v1i1.11
Vancouver
Rahman SF. Synthesis of Fibrin Clot from Fibrinogen Platelet Rich Plasma (PRP) for Scaffold Applications. International Journal of Electrical, Computer, and Biomedical Engineering. 2023. doi:10.62146/ijecbe.v1i1.11
BibTeX
@article{Rahman2023,
author = {Rahman, Siti Fauziyah},
title = {Synthesis of Fibrin Clot from Fibrinogen Platelet Rich Plasma (PRP) for Scaffold Applications},
journal = {International Journal of Electrical, Computer, and Biomedical Engineering},
year = {2023},
doi = {10.62146/ijecbe.v1i1.11}
}
EUVIMED